Chief Scientist Emphasizes AI and Innovation to Support Thalassaemia Community

The chief scientist delivered remarks on advancing thalassaemia care. Emphasis was placed on the potential of artificial intelligence. Innovation was cited as a key driver for improved treatments. Global guidance and collaboration were also highlighted. The focus centered on benefits for the thalassaemia community. The statements were reported by cbn.com.cy. No specific projects or timelines were disclosed. Stakeholders are encouraged to leverage technology for patient outcomes.